The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?

Source:http://linkedlifedata.com/resource/pubmed/id/14962717

Download in:

View as

General Info

PMID
14962717